Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles

Author： Locatelli Francesco   Del Vecchio Lucia   Violo Leano   Pontoriero Giuseppe  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.5, 2014-05, pp. : 551-561

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Optimal use of phosphate binders in chronic kidney disease

By Sonikian Makrouhi   Papachristou Evangelos   Goumenos Dimitrios S  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2521-2532

Informa Healthcare

Access to resources Recommend Favorite

Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease

By Cozzolino Mario   Brancaccio Diego  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 341-343

Informa Healthcare

Access to resources Recommend Favorite

Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

By Mei Sheng Duh  

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 969-976

Adis International

Access to resources Recommend Favorite

Safety of New Phosphate Binders for Chronic Renal Failure

By Loghman-Adham M.  

Drug Safety, Vol. 26, Iss. 15, 2003-01 ,pp. : 1093-1115

Adis International

Access to resources Recommend Favorite

Safety and tolerability of paricalcitol in patients with chronic kidney disease

By Dyer Christopher A  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 717-728

Informa Healthcare

Access to resources Recommend Favorite